Report cover image

Illumina Inc. (ILMN:NASD) - Strategic SWOT Spotlight

Publisher Quaintel Research
Published Jun 20, 2025
Length 110 Pages
SKU # QTELR20123854

Description

Report Spotlight

Illumina Inc. (ILMN:NASD) - Strategic SWOT Spotlight is a comprehensive and easily accessible overview of The Illumina Inc.'s business operations. It provides a Snapshot of the company's position in the industry compared to competitors. The report includs key executives, products and services, ESG spotlight, Corporate Strategy, Business Description, Helicopter view of SWOT Analysis, Competitive Landscape and latest events.

Key Highlights

Illumina, Inc Founded in 1998, the company is headquartered in San Diego, California, United States, develops, manufactures, and markets life science tools and integrated systems for large-scale analysis of genetic variation and function. Illumina operates in two segments: Core Illumina, which serves customers in the research, clinical and applied markets; and GRAIL, which is focused on multi-cancer early detection screening. Illumina offers a comprehensive line of products and services that serve the sequencing, genotyping and gene expression markets.

This includes sequencing and array-based solutions for genetic variation and biological function. Its sequencing and array technologies fuel advancements in the life sciences and molecular diagnostics markets. Illumina also provides tools and services to the applied markets that take advantage of the wealth of genomic information to enable the development of personalized healthcare, enhance agricultural productivity, and gain a deeper scientific understanding of many other diverse biological processes.

Illumina Inc. in the News:-
  • 01-May-2025 - Illumina and Ovation.io launching first-of-kind GLP-1 dataset to accelerate new therapy development
  • 15-Apr-2025 - Illumina and Tempus partner to drive the future of precision medicine through genomic AI innovation
  • 25-Mar-2025 - Illumina Board of Directors elects Dr. Scott Gottlieb Chair, Keith Meister to join Board of Directors
  • 19-Mar-2025 - Alliance for Genomic Discovery completes 250,000 whole genomes to accelerate drug discovery
  • 24-Feb-2025 - Illumina transforms multiomic research with new technologies to unlock deeper understanding of biology
Scope

Company Fundamentals:- These fundamentals offer valuable insights into Illumina Inc. (ILMN:NASD)'s operations, geographical presence, products and services, ESG spotlight, Corporate Strategy, Business Description and SWOT spotlight, aiding in a comprehensive understanding of the organization.

Reasons to Buy
  • Helicopter view of company's internal and external factors through SWOT analysis - Strive Strategic Decision Making with various analyses and identifying potential customers and suppliers. - Mitigate Risk with help of thorough analysis of internal and external factors. Furthermore, develop strategies and contingency plans to address these challenges and minimize their impact on business operations. - Valuable insights from the report enable investors and partners to make informed decisions regarding potential Collaborations, Investments, or Partnerships with the company.

Table of Contents

110 Pages
Table of Contents
Tables
Charts
Illumina Inc. - Key Company Facts
Illumina Inc. - Company Description
Illumina Inc. - Top Executives
Illumina Inc. - Head Office & Locations
Head Office - Country
Illumina Inc. - Products and Services
Products
Services
Illumina Inc. - Corporate Strategy
Illumina Inc. - Business Description
Core Illumina
Illumina Inc. - ESG Spotlight
Environment
Social
Corporate Governance
Illumina Inc. - SWOT Spotlight
Overview
Strengths
Weaknesses
Opportunities
Threats
Competing Players
Snapshot of Competing Players
Agilent Technologies, Inc.
Key Company Facts
Company Description
Agilent Technologies, Inc. - SWOT Spotlight
Agilent Technologies, Inc. - PESTLE Spotlight
Key Financials
Share Price Trend - Jan-2024 to Jun-2025 (Average Share Closing Price)
Key Financial Ratio Analysis
Key Financial Ratio
Charts
Activity Ratio
Charts
Growth Ratios
Charts
Leverage Ratio
Charts
Liquidity Ratio
Charts
Profitability Ratio
Charts
Roche Holding AG
Key Company Facts
Company Description
Roche Holding AG - SWOT Spotlight
Roche Holding AG - PESTLE Spotlight
Key Financials
Share Price Trend - May-2024 to Jun-2025 (Average Share Closing Price)
Key Financial Ratio Analysis
Key Financial Ratio
Charts
Activity Ratio
Charts
Growth Ratios
Charts
Leverage Ratio
Charts
Liquidity Ratio
Charts
Profitability Ratio
Charts
Pacific Biosciences of California Inc
Key Company Facts
Company Description
Key Financials
Share Price Trend - May-2024 to Jun-2025 (Average Share Closing Price)
Key Financial Ratio Analysis
Key Financial Ratio
Charts
Activity Ratio
Charts
Growth Ratios
Charts
Leverage Ratio
Charts
Liquidity Ratio
Charts
Profitability Ratio
Charts
Thermo Fisher Scientific Inc.
Key Company Facts
Company Description
Thermo Fisher Scientific Inc. - SWOT Spotlight
Thermo Fisher Scientific Inc. - PESTLE Spotlight
Key Financials
Share Price Trend - Jan-2024 to Jun-2025 (Average Share Closing Price)
Key Financial Ratio Analysis
Key Financial Ratio
Charts
Activity Ratio
Charts
Growth Ratios
Charts
Leverage Ratio
Charts
Liquidity Ratio
Charts
Profitability Ratio
Charts
BGI Genomics Co Ltd
Key Company Facts
Company Description
Key Financials
Share Price Trend - Jun-2024 to Jun-2025 (Average Share Closing Price)
Key Financial Ratio Analysis
Key Financial Ratio
Charts
Activity Ratio
Charts
Growth Ratios
Charts
Leverage Ratio
Charts
Liquidity Ratio
Charts
Profitability Ratio
Charts
Illumina Inc. - In the News
01-May-2025- Illumina and Ovation.io launching first-of-kind GLP-1 dataset to accelerate new therapy development
15-Apr-2025- Illumina and Tempus partner to drive the future of precision medicine through genomic AI innovation
25-Mar-2025- Illumina Board of Directors elects Dr. Scott Gottlieb Chair, Keith Meister to join Board of Directors
19-Mar-2025- Alliance for Genomic Discovery completes 250,000 whole genomes to accelerate drug discovery
24-Feb-2025- Illumina transforms multiomic research with new technologies to unlock deeper understanding of biology
21-Feb-2025- Illumina and Broad Clinical Labs usher in new era of drug discovery with collaboration to rapidly scale single-cell solutions
19-Feb-2025- Illumina unveils first-of-its-kind spatial transcriptomics technology
Appendix
Definitions
SWOT Analysis
PESTLE Analysis
Value Chain Analysis
ESG Spotlight
Research Methodology
Disclaimer
Contact Us

Search Inside Report

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us